Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00371462 · ClinicalTrials.gov registry record · NA
PDA+: A Personal Digital Assistant for Obesity Treatment
A NA study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT00371462: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT00371462 is a NA study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00371462, a NA study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether including a PDA decision support tool plus distance support enhances the outcomes attainable by the MOVE2! (Managing Obesity for Veterans Everywhere) standard care alone. Primary hypotheses are that obese patients with chronic pain who are randomized to MOVE2! + PDA + Support will a) lose more weight by 6 months, b) show greater maintenance of weight loss at 12 months, and c) display greater reduction in pain intensity and pain-related disability than those randomized to Standard Care. Secondary hypotheses are that MOVE2! + PDA + Support, compared to Standard Care will result in: a) improved quality of life, b) greater treatment adherence, and c) reduced care utilization.
Primary Outcome
Study was terminated by VA. No VA outcome data to report.
Interventions
- BEHAVIORAL Use of PDA + support to reduce weight and pain
- BEHAVIORAL MOVE! level 2 group weight loss counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-09 |
| Phase | NA |
Why NCT00371462 stopped before completion
NCT00371462 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Use of PDA + support to reduce weight and pain is the first listed.
NCT00371462 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00371462 about?
NCT00371462 is a clinical study titled "PDA+: A Personal Digital Assistant for Obesity Treatment". The purpose of this study is to determine whether including a PDA decision support tool plus distance support enhances the outcomes attainable by the MOVE2! (Managing Obesity for Veterans Everywhere) standard care alone. Primary hypotheses are that obese patients with chronic pain who are randomized...
What is the current status of trial NCT00371462?
This trial is currently terminated. It is a NA study. The enrollment target is 70 participants. The study started on 2007-10. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00371462?
The interventions under investigation include: Use of PDA + support to reduce weight and pain (BEHAVIORAL), MOVE! level 2 group weight loss counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00371462?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00371462's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia